Litt’s Drug profile for Famotidine


Breastfeeding
  • Trade Names: Apo-Famotidine; Duexis (Horizon); Durater; Famodil; Famoxal; Ganor; Gastro; Motiax; Mylanta AR; Nu-Famotidine; Pepcid (Valeant); Pepcidine; Pepdul; Sigafam
  • Indications: Duodenal ulcer, gastric ulcer, gastroesophageal reflux disease
  • Class: Histamine H2 receptor antagonist
  • Half-life: 2.5–3.5 hours

Investigated for treating COVID-19.

Duexis is famotidine and ibuprofen.

Please login to view the rest of this drug profile.

Page last updated 11/26/2025

Symbol key

Incidence - Help

<1% 1‑5% 5‑10% 10‑15% 15‑20% 20‑30% >30%

Seriousness - Help

Hospitalization possible
Life threatening
Fatal

Warnings in other populations - Help

BreastfeedingBreast feeding

GeriatricGeriatric

PediatricPediatric